About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Post-acute Care for Patients With Frailty | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT05452395

Post-acute Care for Patients With Frailty

Acute illness could be enormous stress for frail people. Combining comprehensive geriatric assessment and multifactorial intervention has positive effects on frail community older adults. However, few...

Lead sponsor: Taipei City Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Taipei City Hospital

Frail patients aged \>= 75 were recruited and divided into PAC or control groups. The PAC group received comprehensive geriatric assessment (CGA) and multifactorial intervention for two to four weeks. The control group received CGA only. The primary outcomes were 90-day emergency room visits, readmissions, and mortality after PAC.

Age

75 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. Mild to severe frailty identified by the Clinical Frailty Scale
•2. Age ≥ 75 years
•3. Diagnosis with Parkinson's disease, dementia, chronic obstructive pulmonary disease, or chronic kidney disease stage three or worse
•4. Acute hospital stays between 3 to 30 days with deconditioning
•5. Stable medical condition with no need of intensive care, laboratory examination, or oxygen dependence

Exclusion Criteria

•1. Refused to participate in the program
•2. Candidate for other post-acute care programs (i.e. stroke, traumatic neurological injury, or fracture)
•3. Unable to cooperate with the program due to mental or cognitive impairment
•4. Long-term ventilator-dependence
•5. Long-term bed-ridden status (\> 6 months)
•6. Diagnosed as end of life and in need of palliative care
•7. Diagnosed as major illness (i.e. end-stage renal disease) and in need of frequent inpatient treatment ( \> 3 times over recent 6 months)
•8. Institutional residents
•9. Home medical care participants

Related studies

Health Ahead Comparative Effectiveness Study

NCT07669168 · Health Services Accessibility, Rural Health, and more

Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation

NCT07441382 · Atrial Fibrillation (AF), Stroke, and more

Prehabilitation for Ovarian Cancer Patients

NCT05364879 · Prehabilitation, Exercise, and more

CALLY Index, Frailty and SOFA-2 for Mortality Prediction in Geriatric ICU Patients

NCT07579728 · Critical Illness, Frailty, and more

Twice vs Thrice Weekly Incident Hemodialysis in Elderly Patients

NCT06141798 · Age Problem, Dialysis; Complications, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 11, 2022Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment254

Start dateJun 2020

Last updatedJul 11, 2022

Condition

Frailty Retrospective Study

Locations shown

Taipei City Hospital

Taipei

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 11, 2022Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions